Christopher Adams, PharmD, RPh, BCPS

Atrial fibrillation is characterized by abnormal impulse formations that cause the heart to beat irregularly.

Target-specific oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban are now being used in a larger and more diverse patient population.